Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
Novo Nordisk CEO on Wegovy, Ozempic, Profit Forecast, US Market
05:51am, Wednesday, 07'th Aug 2024
Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen discusses Wegovy and Ozempic sales, the US market and the scaling of manufacturing. He speaks to Francine Lacqua on Bloomberg Televis
Ozempic Maker Novo Nordisk Sinks On Disappointing Earnings Amid Booming Demand For Weight Loss And Diabetes Drugs
04:19am, Wednesday, 07'th Aug 2024
Pharma giant Novo Nordisk on Wednesday reported booming demand for its weight loss and diabetes drugs Ozempic and Wegovy, but shares sank after the Danish firm disappointed investors with less-than-ex
Ozempic maker Novo Nordisk falls after cutting profit outlook
03:37am, Wednesday, 07'th Aug 2024
Shares in Novo Nordisk (NYSE:NVO), the maker of weightloss and diabetes drugs Wegovy and Ozempic, fell over 5% after it slightly lowered the profit outlook for this year. Operating profit for Europ
Ozempic maker Novo Nordisk misses profit estimates as it builds out capacity
02:32am, Wednesday, 07'th Aug 2024
Novo Nordisk, Europe's largest company by market cap thanks to its wildly popular weight-loss drugs, managed just a small increase in second-quarter profits as it builds out the capacity to make the p
Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlook
01:48am, Wednesday, 07'th Aug 2024
Novo Nordisk on Wednesday announced its second quarter earnings for 2024.
Obesity drugmaker Novo Nordisk misses Q2 profit forecast
01:37am, Wednesday, 07'th Aug 2024
Novo Nordisk on Wednesday posted second-quarter operating profit below expectations, raised its 2024 sales forecast but cut profit outlook, as competition from Eli Lilly in the booming weight-loss dru
Novo Nordisk A/S - share repurchase programme
07:15am, Tuesday, 06'th Aug 2024
Bagsværd, Denmark, 06 August 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council
Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
12:41pm, Monday, 05'th Aug 2024
Let's look at five biotech and drug companies, AMGN, GILD, LLY, VTRS & NVO, due to release their second-quarter 2024 results this week.
Lilly, Novo Nordisk battle for weight-loss market lands at the pharmacy shelf
06:06am, Monday, 05'th Aug 2024
As Eli Lilly's weight-loss drug Zepbound gains ground in the U.S. against Novo Nordisk's Wegovy, some doctors say their guiding principle for writing prescriptions is simple: which drug can my patient
Fake weight loss drugs spark warnings on Ozempic supply squeeze
02:43am, Monday, 05'th Aug 2024
Pharmacists have warned against buying fake weight loss jabs online as shortages of Ozempic persist in the UK. The National Pharmacy Association (NPA) said patients were risking their health over a po
3 Unstoppable Stocks to Buy in August
07:45am, Saturday, 03'rd Aug 2024
Novo Nordisk is big but has plenty of room to grow. Vertex Pharmaceuticals' existing products and pipeline programs give it multiple growth catalysts.
Eli Lilly vs Novo Nordisk: A Recent Study Suggests This Company Has the Best Weight Loss Drug
06:20am, Saturday, 03'rd Aug 2024
A recent study compared the effectiveness of tirzepatide against semaglutide. Tirzepatide has been more effective in helping people lose weight in trials, and the study corroborated that.
PFE vs. NVO: Which Stock Is the Better Value Option?
12:46pm, Friday, 02'nd Aug 2024
Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Novo Nordisk (NVO). But which of these two stocks offers value investors a bett
What You Need To Know Ahead of Novo Nordisk Earnings Wednesday
06:41am, Friday, 02'nd Aug 2024
Novo Nordisk (NVO) is set to report earnings for the second quarter on Wednesday morning after a first half in which the company's market of potential customers for its Ozempic and Wegovy weight-loss
What Are the Hottest Weight Loss Stocks Right Now? 3 Top Picks.
03:20pm, Thursday, 01'st Aug 2024
Easily one of the biggest trends right now in the field of medicine is the weight loss drug surge. Without attempting to sound cynical, the reality is that the sector enjoys a massive total addressabl
